21 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• Cassava Sciences, Inc. SAVA stock rose 37.5% to $7.15 during Thursday's pre-market session.
• Innate Pharma, Inc. IPHA shares surged 31.3% to $8.44.
• Trillium Therapeutics, Inc. TRIL stock moved upwards by 22.3% to $1.26.
• Medigus, Inc. MDGS stock rose 14.4% to $1.99.
• Jaguar Health, Inc. JAGX stock surged 7.4% to $0.86. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $3.00.
• HEXO, Inc. HEXO stock surged 7.3% to $1.70. According to the most recent rating by Seaport Global, on October 14, the current rating is at Neutral.
• Onconova Therapeutics, Inc. ONTX stock surged 7.0% to $0.41.
• Rite Aid, Inc. RAD stock surged 6.1% to $16.40.
• Veru, Inc. VERU shares surged 5.7% to $3.54.
• Advaxis, Inc. ADXS stock increased by 4.9% to $0.90.
• Savara, Inc. SVRA shares surged 4.9% to $4.70.
• Cellectis, Inc. CLLS stock surged 4.4% to $17.87.
• Mallinckrodt, Inc. MNK shares moved upwards by 3.3% to $3.60.
• Amarin Corp, Inc. AMRN shares surged 3.0% to $22.08. The most recent rating by Oppenheimer, on December 16, is at Underperform, with a price target of $8.00.
• Aurora Cannabis, Inc. ACB shares surged 2.1% to $2.20. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
• Qiagen, Inc. QGEN shares increased by 2.0% to $34.49. The most recent rating by Bank of America, on December 26, is at Underperform, with a price target of $28.00.
• Novo Nordisk, Inc. NVO stock increased by 1.5% to $58.75. According to the most recent rating by UBS, on November 18, the current rating is at Neutral.
• Canopy Growth, Inc. CGC shares rose 1.5% to $21.40. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
• Medtronic, Inc. MDT stock surged 1.0% to $114.55. The most recent rating by Guggenheim Securities, on January 02, is at Buy, with a price target of $135.00.

Losers

• Viveve Medical, Inc. VIVE stock declined 12.7% to $1.10 during Thursday's pre-market session. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
• Ocugen, Inc. OCGN shares fell 3.6% to $0.50. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.